MLPNX
Price
$7.79
Change
+$0.12 (+1.56%)
Updated
Jun 2 closing price
Net Assets
331.2M
SPMPX
Price
$7.45
Change
+$0.11 (+1.50%)
Updated
Jun 2 closing price
Net Assets
331.2M
Interact to see
Advertisement

MLPNX vs SPMPX

Header iconMLPNX vs SPMPX Comparison
Open Charts MLPNX vs SPMPXBanner chart's image
MLPNX vs SPMPX Comparison Chart in %
View a ticker or compare two or three
VS
MLPNX vs. SPMPX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPNX is a Buy and SPMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPNX (331M) and SPMPX (331M) have equal amount of cash in the bank . SPMPX (4.88) and MLPNX (4.67) have matching dividends . MLPNX was incepted earlier than SPMPX: MLPNX (14 years) vs SPMPX (7 years). MLPNX (3.49) and SPMPX (3.42) have similar cost to investors . MLPNX (25.00) and SPMPX (25.00) have comparable annual turnover. MLPNX has a lower initial minimum investment than SPMPX: MLPNX (1000) vs SPMPX (1000000). SPMPX (27.63) and MLPNX (27.60) have marching annual gain over last year. SPMPX (229.36) and MLPNX (228.23) have equivalent 5 years return.
MLPNXSPMPXMLPNX / SPMPX
Total Expense Ratio3.493.42102%
Annual Report Gross Expense Ratio3.493.42102%
Fund Existence14 years7 years-
Gain YTD23.53723.595100%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets331M331M100%
Annual Yield % from dividends4.674.8896%
Returns for 1 year27.6027.63100%
Returns for 3 years126.01126.27100%
Returns for 5 years228.23229.36100%
Returns for 10 years151.44N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMG310.528.07
+2.67%
Affiliated Managers Group
EPAC33.160.23
+0.70%
Enerpac Tool Group Corp
HBANP16.50-0.10
-0.60%
Huntington Bancshares
MKTW17.14-0.12
-0.67%
MarketWise Inc
AVIR4.28-0.11
-2.40%
Atea Pharmaceuticals